4.5 Article

Acute myocarditis after COVID-19 vaccination with mRNA-1273 in a patient with former SARS-CoV-2 infection

Related references

Note: Only part of the references are listed.
Letter Medicine, General & Internal

Thromboembolism and the Oxford-AstraZeneca COVID-19 vaccine: side-effect or coincidence?

Soren Dinesen Ostergaard et al.

LANCET (2021)

Article Pathology

Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19

Mayara Bearse et al.

Summary: COVID-19 is associated with cardiac injury and dysfunction, with cardiac infection by SARS-CoV-2 being common among patients who have died from the disease but often with only rare infected cells. Cardiac infection by SARS-CoV-2 is linked to more cardiac inflammation and electrocardiographic changes. Nonbiologic immunosuppression is associated with lower incidences of myocarditis and cardiac infection by SARS-CoV-2.

MODERN PATHOLOGY (2021)

Article Biochemistry & Molecular Biology

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2

Joseph E. Ebinger et al.

Summary: Virus-specific antibody levels after a single dose of the BNT162b2 vaccine in individuals previously infected with SARS-CoV-2 are similar to levels after two doses of the vaccine in infection-naive individuals. Post-vaccine symptoms were more prominent for those with prior infection after the first dose, but symptomology was similar between groups after the second dose.

NATURE MEDICINE (2021)

Letter Cardiac & Cardiovascular Systems

Myocarditis After BNT162b2 and mRNA-1273 Vaccination

Kathryn F. Larson et al.

CIRCULATION (2021)

Letter Cardiac & Cardiovascular Systems

Myocarditis Temporally Associated With COVID-19 Vaccination

Carolyn M. Rosner et al.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis

Adam L. Bailey et al.

Summary: The study provides evidence that cardiomyocytes are infected in patients with COVID-19 myocarditis, leading to severe acute respiratory syndrome coronavirus 2 infection that results in various detrimental effects, including contractile deficits and cell death.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)

Editorial Material Cardiac & Cardiovascular Systems

SARS-CoV-2-related myocarditis-like syndromesShakespeare's question: what's in a name?

Sophie Van Linthout et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Article Cardiac & Cardiovascular Systems

Myocardial localization of coronavirus in COVID-19 cardiogenic shock

Guido Tavazzi et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Review Cardiac & Cardiovascular Systems

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

Masataka Nishiga et al.

NATURE REVIEWS CARDIOLOGY (2020)